The goal of the meeting is to provide an action plan that will increase the likelihood of children and adolescents with cancer benefitting from both the EU Paediatric Medicines Regulation (Regulation (EC) No 1901/2006) and EU-funded structuring activities. Join representatives from academia, the pharmaceutical industry, the European Medicine Agency (EMA), the EMA Paediatric Committee, Government bodies, Members of the European Parliament (MEPs) as well as parents and patients and discover the recent advances in the field of paediatric oncology. Should you require any additional information please do not hesitate in contacting the BDA Oncology Secretariat directly via E-mail: bdaoncology@kpnmail.nl or Tel.: +31 299 413 005.